The invention relates to a method for establishing a
uterine cavity body fluid detection
system, which comprises the steps of
sample collection, pretreatment and detection, the sample is
uterine cavity trace
cell suspension supernatant, and the detection is to detect the marker content and metabolic
enzyme of the
uterine cavity trace
cell supernatant. The markers are CA125, CA153, CA199, CEA (Carcino Embryonic Acid), SCC (Sequence Cells Cells), AFP (Alpha
Fetal Protein), HE4 ( The
metabolic enzymes are AST, ALP, CK, LDH, ALT and GGT. The invention also provides a biomarker combined
reagent used in the method for establishing the uterine cavity
body fluid detection
system. The invention creates a new
body fluid detection
system, and has originality. The operation is simple and convenient, and no operation is needed. According to the invention, trace endometrial cells are collected by using an endometrial sampler,
tumor marker and metabolic
enzyme detection is carried out on
cell suspension supernatant, and a novel body fluid diagnosis system for
endometrial cancer marker detection is established. According to the invention, a uterine cavity
endometrial cell sample is directly adopted, and a
target tissue is directly locked in space, so that the specificity and sensitivity of
endometrial cancer detection are enhanced.